- From: Eric Neumann <eneumann@teranode.com>
- Date: Thu, 26 Oct 2006 17:48:44 -0400
- To: Kerstin.L.Forsberg@astrazeneca.com, Bo.H.Andersson@astrazeneca.com, "James McGurk" <james_mcgurk@merck.com>, "Ted Slater" <ted.slater@pfizer.com>, "Uwe Trinks" <Uwe.Trinks@sentrx.com>
- cc: public-hcls-dse@w3.org
Folks,
We are still on for tomorrow's 9-10am EDT call, though Kerstin has informed my she can not make it. If enough need to excuse themselves we could reschedule, but I would suggest we try and move things forwards with this next call. BTW, Has everyone subscribed to the new list: public-hcls-dse@w3.org ?
I also met briefly with Wayne Kubick today (Lincoln Tech is part of Phase-Forward now), and gave him an overview of what we've discussed and plan to do. He has offered to get us more closely connected with the BRIDG project (SW and model alignment), so we should also discuss this option.
Proposed Agenda: Discussion around SDTM Model, it's current functional specs, and it's limitations...
- please see http://esw.w3.org/topic/HCLSIG/Drug_Safety_and_Efficacy?action=AttachFile&do=get&target=CRT_DDSpecification1_0_0.pdf,
http://esw.w3.org/topic/HCLSIG/Drug_Safety_and_Efficacy?action=AttachFile&do=get&target=CDISC+SDTM+overview.doc, and http://esw.w3.org/topic/HCLSIG/Drug_Safety_and_Efficacy?action=AttachFile&do=get&target=CDISCs+SDTM+basics.ppt
cheers,
Eric
Received on Thursday, 26 October 2006 21:50:09 UTC